IL3RA and acute myeloid leukemia: Recent studies carried out by Larsen and coworkers have identified the human Myeloid Inhibitory C type-like lectin (hMICL) as a stable and reliable AML antigen expressed in 90% of AML samples, as well as CD123 [50]; importantly, the expression of these two antigens remained constant in paired samples at diagnosis and at relapse [50].